3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma, Follicular
1
Hemophilia A
1
Castrate Resistance Prostate Cancer
1
Interventions
Cyclophosphamide
17
Rituximab
12
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Filgrastim
7
sargramostim
6
Vincristine
6
fludarabine phosphate
5
Radiotherapy
5
Doxorubicin
5
Cytarabine
5
Cisplatin
5
ibritumomab tiuxetan
4
Methylprednisolone
4
Melphalan
4
Etoposide
4
Dexamethasone
4
Cyclosporine
4
epratuzumab
3
Sensitivity and Specificity
3
Polymerase Chain Reaction
3
Mycophenolic Acid
3
Indium
3
Chlorambucil
3
Busulfan
3
Bendamustine Hydrochloride
3
Antilymphocyte Serum
3
Antigens, CD19
3
obinutuzumab
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Follicular
×
Deamino Arginine Vasopressin
×
Clear all
NCT05628558
2022-11-28
GIDEMHA
Groupe Maladies hémorragiques de Bretagne
Unknown
800 enrolled